HopeStage
Back to all studies
CompletedNCT03274440

Cannabis or Placebo and Obsessive-Compulsive Symptoms

About this titleRead the official source — NCT03274440

Researchers compared Cannabis and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.

Medication studyAges 21–55United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Cannabis and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.

Who was this study for?

Listed age limits: 21 years to 55 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 1, 2017
Recruitment status
Completed
Enrollment listed in the registry
14
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 21 Years to 55 Years
Official registry ID
NCT03274440
Official title
Show the full official title

Effects of Marijuana on Symptoms of Obsessive-Compulsive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Cannabis and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Cannabis.

Who was this study for?

Listed age limits: 21 years to 55 years.

Want to explore more studies?

Explore studies